Mizuho analyst Steven Valiquette reiterated a Neutral rating and $7.00 price target on LifeMD Inc (NASDAQ: LFMD).The analyst comments "Post-ITCI's ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE